The Biosimilar Experts Who we are Formycon AG is a leading, independent developer of high-quality biosimilars, follow-on products of biopharmaceutical medicines. The company focuses on therapies in ophthalmology, immunology, immuno-oncology and other key disease areas, covering almost the entire value chain from technical development through clinical trials to approval by the regulatory authorities. For commercialization of its biosimilars, Formycon relies on strong, well-trusted and long-term partnerships worldwide. About Biosimilars: Since their introduction in the 1980s, biopharmaceutical drugs have revolutionized the treatment of serious and chronic diseases. By 2032, many of these drugs will lose their patent protection – including 45 …

85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Enabling same-day cancer diagnostics from minimally invasive sample material X ZELL is a global pioneer in multiplexed immunostaining – a patented technology set to revolutionize cancer diagnostics by applying multiple diagnostic antibodies simultaneously to a single specimen. Our FDA and CE IVD registered next generation cytology platform was specifically designed for minimally invasive cytology samples and processes up to eight antibodies at once – maximizing diagnostic yield while cutting turnaround by over 90%. No complex preparation. No sample wastage. By combining multiplexing with cutting edge digital imaging, we help laboratories deliver faster, more patient friendly, and personalized care – ready …

119 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Synthetic Biology

Leading the Way in Pancreatic Cancer Diagnostics Immunovia AB is a diagnostic company whose mission is to increase survival rates for patients with pancreatic cancer through early detection. Immunovia is focused on the development and commercialization of PancreaSure, a simple blood-based test to detect proteins and antibodies that indicate a high-risk individual has developed pancreatic cancer. Immunovia collaborates and engages with healthcare providers, leading experts and patient advocacy groups to make its test available to individuals at increased risk for pancreatic cancer. Pancreatic cancer, Early diagnosis of cancer, Cancer therapy monitoring, Patient classification, Blood-based tests, Antibody microarray technology, Serum biomarker …

84 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The synthetic collagen revolution NVH Medicinal world expert in synthetic collagen NVH Medicinal is a biotechnology company based in Dijon, created at the end of 2008 whose mission is based on the treatment of pathologies linked to a collagen deficiency. It develops products derived from collagen, the most abundant protein in the body and whose dysfunctions cause numerous diseases (aging, cardiovascular, inflammatory, neurological diseases, fibrosis, cancer and rare diseases). NVH's ambition is to be recognized as an innovative player in the treatment of collagen-related diseases by becoming one of the world leaders in the development, production and marketing of a …

77 similar entities Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

Visionary science. Every day human tissues are thrown away after surgery. At CTIBIOTECH we save them and give them new purpose, To advance human therapies, to develop new medicines, to test cosmetics or test anything that comes into contact with us. For a better human world. Founded in 2009, we have laboratories in Lyon, France and Philadelphia, USA. We have 4 wings to our company: CTIBIOSOURCING - providing human tissues, cells and culture media globally. CTISKIN - the world's most advanced manual and 3D Bioprinted human skin models for drug, device and cosmetics testing. CTIPHARMA - sophisticated human tissue models …

98 similar entities Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology

The leading experts in cancer cell capture and analysis from liquid biopsies ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. ANGLE’s commercial businesses are focusing on diagnostic products and clinical services. Diagnostic products include the Parsortix® system and associated consumables. …

277 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes in patient management. The Company uses its expertise in antibodies and assay development, as well as its platform for assay development, to create a pipeline of novel and compelling products that focus on conditions where there is significant unmet medical need, and where the Company’s tests can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem. The Company’s flagship products, ProNephro AKITM and The NGAL TestTM, are based …

137 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Built on Trust. Driven by Science. Focused on You. BÜHLMANN Laboratories AG is a fully independent, mid-sized Swiss company founded in 1976. With local teams in Switzerland, France, Italy, Germany, Austria, the USA, and Brazil, as well as distributors worldwide, BÜHLMANN has established itself as a leader in the field of specialty in-vitro diagnostics. Recent milestone: On June 5, 2024, BÜHLMANN was acquired by KLAR Partners to support the company's continued growth. BÜHLMANN has quickly become a leading provider of calprotectin tests, offering the broadest range of available solutions, including fully automated, high throughput turbidimetric and ELISA assays (BÜHLMANN fCAL® …

76 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Targeted Enzyme Delivery to improve thrombolysis TargED started in September 2018 and is currently developing one biopharmaceutical product: MICROLYSE. MICROLYSE enzymatically breaks down blood clots in small blood vessels (i.e. the microvasculature), for which to date, no specific treatment exists. TargED pursues to receive market authorization for an orphan disease named Thrombotic Thrombocytopenic Purpura (TTP) that is characterized by life threatening attacks of microvascular thrombosis. However, MICROLYSE has the capacity to target all forms of microvascular thrombosis and could also be applied in early-stage macrovascular thrombosis as seen in heart attacks and stroke. Biologicals, Thrombolysis, and Microvascular thrombosis

58 similar entities Type: Startup Activities: deeptech biotech

Redefining Early Stage Development BDD combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products. Rapid parallel clinical testing with BDD SWIFT significantly reduces the time from product concept to clinical success. Recognizing that one size does not fit all we specialise in providing responsive, flexible and innovative solutions to our customers. Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time. Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through …

141 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Cloud Based Haematology Diagnostics Delivered aaS RheoDx is a diagnostics company committed to improving the quality of life of hematology patients and the efficiency in their clinical management. Develops an inexpensive medical device that monitors red blood cells conditions in less than five minutes with a drop. Its small size and simplicity allow to be used at the point-of-care and at home. Spin-off of the Centre Recerca Matemàtica (CRM), and incorporated in the Collider, the venture builder of tech transfer by Mobile World Capital Foundation. Medical Devices, In vitro diagnostics, Hematology, Point-of-care, Transfusions, and Blood cells conditions

202 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

VarmX is a young biotech company focusing on the development of therapies in the field of hemostasis and thrombosis. VarmX (www.varmx.com) is a young Leiden based biotech company that is focusing on the development of therapies in the field of hemostasis and thrombosis. Originally a spin-off from the Leiden University Medical Center (LUMC), our mission is to develop and manufacture therapeutic proteins to restore hemostasis. Our lead compound, VMX-C001, is intended to safely and effectively restore hemostasis in case of bleeding or emergency surgery in patients taking so-called oral factor Xa inhibitors. The VarmX program has gained significant interest in …

76 similar entities Type: Startup Activities: manufacturing deeptech biotech healthtech Technologies: Synthetic Biology

Industrial microbiology testing providing immediate results at performance and ease-of-use never reached before. Redberry - A Lonza company - offers rapid testing solutions aimed at avoiding the culture phase of microorganisms in industrial microbiology and thus providing immediate results at cost, performance and ease-of-use never reached before. We work with Pharmaceutical and Personal Care Product manufacturers. We also offer solutions for Water professionals and collectivities. Available applications : ►ATMP Release testing : Rapid 3-Level Approach ►Sterility testing for Pharma Products : 4 days results with full compendial sample preparation - Primary validation package available with full equivalency. ►Rapid Bioburden for …

132 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Innovative scientific services on efficacy testing for bioactives or formulated products to support healthy aging. OxiProteomics is a CRO French specialized in biomarker assessment providing research services for skin care dermo-cosmetics, medical devices, and dermatology efficacy evaluation. Spined-out from Sorbonne University in 2014, our uniqueness is a specific know-how on non-targeted & targeted proteomics approaches adapted to skin and hair evaluation. We support our clients on molecular target identification, target validation, efficacy testing, mechanistic studies, prediction of responders, and biomarkers discovery. We also propose predictive pre-clinical skin models coupled with spatial proteomics analyses, based on the organ culture of human …

99 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Best-in-class monoclonal antibodies with Human Fc for IVD Based in Illkirch-Graffenstaden (France), Bcell Design redefines the standards of diagnostic excellence by providing cutting-edge solutions that address the industry’s most pressing challenges. We specialize in developing, producing, and commercializing monoclonal antibodies with Fc human domains: a superior alternative to disease plasma. Our antibodies are designed to deliver unmatched sensitivity and specificity, ensuring consistent and reliable performance for diagnostic test manufacturers worldwide. What sets us apart? → Unparalleled accuracy: Our monoclonal antibodies raise the bar with precision and performance you can trust. → Reliability you can count on: Designed to eliminate variability …

105 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Science Accelerated KCAS Bio - Lyon (Active Biomarkers) operates as a bioanalytical laboratory based in Lyon, France and headquartered in Olathe, Kansas, USA. We offer comprehensive service solutions for the development of both large and small molecules, with extensive capabilities and expertise in pharmacokinetics, immunogenicity, soluble and cellular biomarker analysis for clinical trials. Operating in state-of-the-art BSL2 facilities, our company is GLP certified and ISO 9001:2015 certified, with a unique track-record in the development, validation, and implementation of analytical methods. Our expert team has supported hundreds of studies in multiple therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases. …

107 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology Data Analytics

Scientist-to-Scientist Fluofarma, a Porsolt company, joins drug discovery projects to bring tailored solutions in cell biology and high-content analysis. Specialized in assay design, the French preclinical CRO develops and performs cell-based assays and quantifies biomarkers in blood and tissues using different high-content imaging and flow cytometry technologies. Fluofarma's contract research services are based on the following capacities: CUSTOM BIOLOGICAL MODELS > Generation of primary cell cultures, cell lines, 3D spheroids > Development of multi-cell type culture systems in 2D & 3D > Preclinical and clinical samples : whole blood, solid tissues and tissue microarrays (TMAs) ADAPTATION & DEVELOPMENT OF CELL-BASED …

75 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Preclinical CRO in Hematological Cancers Diag2Tec is an expert preclinical CRO devoted to hematological cancers, especially Multiple Myeloma (MM). We focused on in vitro Drug Testing in Human Hematological Cancer derived Cell Lines and Primary Cells from patients with various Hematologic Malignancies (Multiple Myeloma, Diffuse Large B Cells Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Mantle cell Lymphoma, Chronic Lymphoid Leukemia...). With our 2 platforms : Drug Testing Services and ChimioFx, our mission is to provide efficient treatment solutions for patients suffering from Hematological Malignancies with Precision Medicine approaches. We support biotech and phamaceutical companies to focus their drug development on …

67 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Laboratory Testing Excellence Eurofins Biolab S.r.l. is a GMP & GLP Laboratory part of the BioPharma Product Testing Division of Eurofins Scientific. Pharmaceuticals, Medical Devices, Biocides and Cosmetics are our main areas of interest GMP, GLP, ISO 17025, ISO 9001, ISO 13485, ISO 22716, FDA INSPECTED, BioPharmaceutical Testing, Medical Device Testing, Biocide Testing, Cosmetic Testing, Professional Scientific Services, Regulatory and Consultancy, Microbiological and Chemical Testing, Training, and Laboratory Testing

244 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Fluid Management Equipment Built For You As a global partner to the biopharmaceutical industry, Asahi Kasei Bioprocess helps biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably supplying innovative yet exceptionally reliable bioprocess consumables, equipment and scientific support services. Our portfolio is anchored by PlanovaTM virus removal filters. First released in 1989 as the world's first hollow fiber filter developed specifically for removing viruses from biotherapeutic drug products, PlanovaTM filters ensure viral safety of biopharmaceutical drug products, thanks to their high quality and consistent performance. Leveraging 30 years of experience, we continue to provide our customers …

88 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, …

84 similar entities Type: Startup Activities: deeptech healthtech manufacturing

GlycoBAR: a new and cost effective way to get rid for blood group antibodies. No blood group barrier any more ! GlycoBAR sells blood group antigen ligands that can be used to make plasma "Universal" (=compatible with all recipients, whichever the blood group of the donor is). Our ligands are also allowing transplant of organs when donor and recipients are belonging to incompatible blood group Biofermentation, Blood purification, Blood group antibody removal, and Isoagglutinins removal

62 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Assesses your product's future Eurofins Cosmetics & Personal Care is an aligned network of first-class laboratories across Europe, North America, Asia, Oceania and Africa, using the latest technologies and providing an unrivaled range of clinical, sensory, chemical, in vitro and microbiological testing services. Established in 1990 and in continuous expansion ever since, Dermscan joins Eurofins in 2018 in line with Eurofins Cosmetics’ strategy to expand its leading global cosmetic testing footprint. ISO 9001: 2015 certified, Eurofins Dermscan assess the safety, tolerance and efficacy of raw materials, finished products, food supplements, medical devices, etc. Thanks to facilities in France, Poland, Tunisia, …

71 similar entities Type: SMB Activities: biotech deeptech cosmetics Technologies: Synthetic Biology

At Tethis we aim to make liquid biopsy a standard, reproducible, oncology diagnostic. Our proprietary slides allow immediate, fully automated and gentle processing of blood samples, three unaddressed elements that are crucial to ensure standardization and to maintain clinical informativity. High throughput analytical protocols are then performed for highly sensitive and specific blood-based cancer testing in different clinical settings.

59 similar entities Type: Startup Activities: deeptech biotech

The clear path to small molecule visualization & quantification Over the past decade, Immusmol specialized in the development of antibodies against low molecular weight compounds (<900 Daltons), eventually building a portfolio of unique primary antibodies and ELISA kits for research use. 50 + unique primary antibodies We develop monoclonal & polyclonal antibodies and staining procedures for the visualization of small molecules in cells & tissues. 80+ ELISAs cross-validated by LC-MS Our team develops highly sensitive ELISA kits to measure amino acids and their metabolites in biological samples. 600+ clients served worldwide We deliver our products worldwide through Fedex and developed …

114 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Fighting Inflammation at its Source Invizius is a spin-out based on world-class Complement research carried out at the University of Edinburgh, Scotland. Complement is 1.3b years old and part of the innate immune system. As it is the most ancient part of the immune system it is involved at the beginning of every inflammatory response. We fight inflammation at its source. Invizius is developing Second Generation Complement Therapeutics to significantly improve the clinical outcomes of patients with dysregulated complement systems leading to inflammation and fibrosis. Our first indication for H-Guard is in Acute Kidney Injury receiving CRRT where there is …

63 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Unlocking the potential of solid samples in the field of biological diagnostic Diagante develops a solution for in vitro diagnostics. Its platform allows the analysis of solid clinical specimen on rapid and high throughput instruments in clinical pathology labs. It provides faster results, enhanced personalized medical care, and lower costs to the stakeholders.

150 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for …

110 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

A division of Cerba Research For nearly 10 years HISTALIM provides services in the fields of histology, cytology and molecular biology for clients from a wide range of sectors including human and animal health, dermo-cosmetics, chemistry, environment, agronomics, agri-food industry... Ranging from neurosciences to toxicity assessment, from the characterization of therapeutic antibodies to the evaluation of implantable medical devices..., our teams focus on accompanying each client to provide each of them with a perfectly controlled service. Our histological technical resources, our European network of histopathology experts, and our techniques in image processing and analysis enable us to meet efficiently each …

90 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Heidelberg Pharma is a biopharmaceutical company working on a new treatment approach in oncology and developing novel drugs based on its ADC technologies for the targeted and highly effective treatment of cancer. ADCs are antibody-drug conjugates that combine the specificity of antibodies with the efficacy of toxins to fight cancer. Selected antibodies are loaded with cytotoxic compounds, the so-called payloads, that are transported into diseased cells. Inside the cells, the toxins then unleash their effect and kill the diseased cells. Heidelberg Pharma uses several compounds and has built up an ADC toolbox that overcomes tumor resistance via numerous pathways and …

201 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unique concept for MS-based absolute quantification of blood proteins ProteomEdgeTM is a company from Stockholm, Sweden, with a mission to bring precision into MS-based absolute quantification of blood plasma proteins. Our proprietary analysis platform offers cleavable heavy-isotope labeled protein standards for targets of both clinical and research interests that is versatile and easy to use. The technology ensures state-of-the-art accuracy in absolute protein quantification using mass spectrometry within a unique format that allows for addition-only protocols and straightforward handling in fully automated pipelines. Our products offer various protein panels for multiplexed analysis of human blood plasma proteins delivered prealiquoted and …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Your partner for preclinical research in Osteoarticular diseases, Inflammation, Skin diseases... Atlantic Bone Screen is a leading CRO (« Contract Research Organization ») specialized in high-quality preclinical evaluation services in the field of inflammation, osteoarticular diseases and skin diseases. Thanks to its high expertise, Atlantic Bone Screen evaluates drug candidates, biomaterials (either for orthopedic or dental applications) and ingredients/products for cosmetics and food industry. We provide high-quality services to support the characterization of drug candidates, nutraceuticals, biomaterials,... Located in Nantes, North-West of France and created in 2005, Atlantic Bone Screen puts at your disposal a unique preclinical platform with a …

63 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes. The Company’s first product is ColdZyme®, a mouth spray which protects against common cold, can help shorten the duration of a common cold if used at an early stage of the infection, alleviates common cold symptoms and soothes sore throat. Our head office is in Lund, Sweden, but we also have an office in Reykjavik, Iceland. For product info, please visit at www.coldzyme.co.uk. Cold and Flu, Enzyme (trypsin), and Barrier technology

219 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

We are your responsive, reliable, and resourceful CDMO Partner. Streamline your biomanufacturing programs with Cytovance Biologics! Born from a decades-long history in drug development, we believe in creating a healthier world where every biologic’s path to commercialization is advanced by a CDMO partner that delivers ingenuity end-to-end. Whether your large molecule product needs the flexibility of a customized approach or the efficiency of a predetermined platform process, Team Cytovance has the deep expertise in microbial and mammalian expression systems to support your scale-up at every stage. From early needs like cell line development and strain selection to cGMP manufacturing for …

192 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Revolutionising Cancer Detection Through Liquid Biopsy The Vortex VTX-1 CTC isolation platform combines high-performance engineering with clinical simplicity. Compact, automated, and easy to integrate, our solution delivers high-purity CTCs ready for downstream analysis—without the need for complex protocols or extensive training. Precision medicine starts here Circulating Tumor Cells, Cancer biomarkers, Microfluidic, Cancer research, Cancer diagnosis, Liquid biopsy, and Cancer monitoring

281 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Precision medicine giving hope Biohope is a commercial-stage biomedical company focused on the research and development of PRECISION MEDICINE IVD tools, to improve clinical outcomes in patients with chronic inflammatory conditions and autoimmune diseases. Biohope has developed an in vitro diagnostic kit called Immunobiogram® to facilitate personalized drug treatment for patients with chronic inflammatory diseases. The first product, for kidney transplant patients, has shown positive results in our clinical studies. The immunobiogram® is a cellular functional assay to help prescribe immunosuppressants. It provides the level of sensitivity of the patient's immune cells to immunosuppressive drugs in order to facilitate personalized …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Sterile Solutions, Built Differently. ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. Our sites in Visp and Basel 🇨🇭 support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients. More about us: www.ten23.health Subscribe our newsletter: www.ten23.health/ten23-health-newsletter biopharmaceuticals, pharmaceutical industry, Contract Manufacturing, Sterile Manufacturing, Aseptic Manufacturing, Drug Device Integration, Analytical Development, Analytical Testing, Molecule Selection, Packaging , and Formulation Development

412 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

First Swiss Liquid Biopsy for the early detection of cancer based on a new innovative transformational biomarker About 4D Lifetec AG 4D Lifetec is a pioneer on a mission to revolutionize early cancer detection. Our easy and powerful blood tests can detect cancer at its earliest stages (I and II), offering you peace of mind and proactive well-being protection. Sophisticated artificial intelligence (AI) enhances our immunological high-throughput blood assays which in turn enables timely intervention and treatment. Molecular Diagnostics, Oncology, Genotoxicity, DNA Damage and Repair, Liquid Biopsy, Biomarker, Early cancer detection, Early cancer diagnosis, Cancer test, Lung Cancer, and Bronchoscopy

114 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I.

Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, …

589 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Technoclone is a producer of #diagnostic tests, equipment and research products in the area of #blood #clotting At Technoclone we see innovation as our duty to help overcome new complexity in the diagnostics of hematological and cardio-vascular disorders. Today more than ever. Technoclone is a world-leading producer of diagnostics tests; equipment’s and research products in the area of blood clotting and offers one of the most complete product portfolios on the market. The Ceveron 100 series is the first fully automated coagulation analyzer series for clotting, chromogenic, turbidimetric assays, thrombin generation and quenching technology (as for FXIII & ADAMTS13 activity). …

65 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Analytical CRO devoted to bioanalysis and quality control of small molecules, biologics, TIDES and advanced therapies. Kymos Group is an analytical CRO devoted to bioanalysis and CMC services for small molecules, biologics and nucleic acids. We are GMP and GLP certified and we have been inspected by EMA and FDA. We work for biotechnology, pharmaceutical, veterinary, fine chemistry, cosmetics and nutraceutical industries. The company premises are located in Cerdanyola del Vallès (Technology Park) where we have a two stand alone buildings: one of 1,500 m2 for laboratories and a second one of 1,000 m2 for offices. Our labs are fully …

193 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Europhartech, a company of the Dômes Pharma group Production site of the Dômes Pharpe Europhartech Group is also CMO (Contracting Organization contract) for the human and veterinary pharmaceutical industry. Specialized in clinical lots, the production of dry forms and non -sterile liquid forms for human and veterinary use as well as in food supplements, additional food and medical devices. Europhartech also has solid expertise from Princeps, ATU/AMM Hospital and EHPAD Unit Bud, PDA, Generic and Nutraceutic. Europhartech is a subsidiary of the pharmaceutical group Dômes Pharma specializing in animal health and present in human health since 1992. Laboratory approved by …

206 similar entities Type: SMB Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Centre d'Etudes Biologiques et Pharmaceutiques OUR MISSION: Provide analytical support for all product development phases (human & veterinary medicines + Medical Device) with: Consulting and expertise Formulation development support Analytical method development and validation Stability studies QC testing Veterinary pre-clinical and clinical studies Analyse pharmaceutique, Pharmaceutical analysis, Contract Research Organization (CRO), Développement analytique, Contrôle qualité pharmaceutique, Quality control (QC), Method development, Analytical method validation, ICH guidelines, ICH Q2 / ICH Q14, Validation analytique, Transfert de méthodes, Biopharmaceuticals, Small molecules, sterile products, Vaccins, Stability studies, Regulatory affairs, GMP compliance, GLP compliance, CCIT (Container Closure Integrity Testing), Extractables & Leachables, Elemental impurities …

135 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Our specificity, your antibodies Pioneer in antibodies’ field, Agro-Bio provides you its expertise and its know-how for production, development and characterization of antibodies. For over 40 years, our team supports pharmaceutical and in vitro diagnostic industries as well as public institutions for their immunology issues. We collaborate both to offer you the most suitable and effective solution. Our goal is the success of your projects. Our services around antibody: • Bioanalysis/Biopharma: o Anti-idiotypic antibodies for positive control, PK and potency test, o Host Cell Protein issue management: specific anti-HCP antibodies, 2D Western Blot coverage analysis, specific ELISA kit, o Epitope …

84 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The cosmetic expertise from the ingredient to the finished product Specialized in the assessment of finished cosmetic products, ingredients and cosmetic raw materials, we perform tolerance and efficacy studies. BIO-HC in-vitro : toxicological and pharmacological tests on cell models (primary cells, cell lines) and tissue models (epidermis, skin reconstructed in vitro). In vitro tests, GLP studies, and OECD tests

76 similar entities Type: SMB Activities: biotech deeptech cosmetics Technologies: Synthetic Biology

Covalab is a French biotechnology company specialized in antibody engineering, founded in 1995. We are expert in the design and development of antibody (polyclonal, monoclonal scFv, FAb, VHH, recombinant antibodies) using antigen or DNA immunization. In addition, we offer purified and labeling antibodies, peptide synthesis for research use, diagnostic and therapeuthic. As a producer, we supply many distributors to sale our innovative and high quality antibodies. Wide range of those products are available in our website. The service activity of CovalAb represents the top of the scientific and technical iceberg which the team at CovalAb has put together. Indeed, the …

106 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Aidian develops, manufactures and markets diagnostic tests and test solutions. Aidian – Your aid in diagnostics We are a leading in vitro diagnostics (IVD) company established in 1974 in Finland. Specialising in point-of-care testing (POCT), we want to provide tools empowering healthcare professionals to make evidence-based diagnoses and treatment decisions. Our aim is to aid health globally by promoting efficient healthcare through accurate and fast diagnostics. We develop, manufacture, and distribute reliable and fast CE-marked diagnostic tests, especially for primary care. Our product portfolio includes solutions among others for infectious disease diagnostics, improved management of diabetes, and colorectal cancer screening. …

237 similar entities Type: SMB Activities: deeptech healthtech

Manufacturer of Laboratory Instruments and Automated Systems iLsa is a key player in the field of laboratory instrumentation for in-vitro diagnostics with 40 years of experience and 10,000 instruments installed world-wide. 2 industrial sites : Besançon (France) : R&D and instruments manufacturing. Saint Ouen l’Aumône (France) : R&D and plastic consumables manufacturing in automated clean room. ILSA activity is based on two departments : iLsa Manufacturing designs and manufactures instruments and plastic consumables for In Vitro Diagnostic companies. iLsa Diagnostic is present on the international market - For Blood Transfusion Centers and Bio-Banks, iLsa Diagnostic is the market leader in …

74 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

QIMA Life Sciences (formerly Bioalternatives, Synelvia, Newtone Technologies and Monasterium Laboratory) is a Contract Research Organization (CRO) specializing in cellular and molecular pharmacology. We offer assays ranging from in silico screening to non-invasive clinical sample bioanalysis, as well as in vitro and ex vivo assays. QIMA Life Sciences contributes to the development of in vitro methods, by offering solutions dedicated to preclinical research and to the development of drug candidates and to cosmetic active ingredients and formulations. QIMA Life Sciences can assist the health industry with its new strategic choices and helps the marketing and R&D departments to innovate in …

117 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

BioCytex is a contract research organization specializing in biomarker detection and analysis of normal and pathological cells in whole blood, bone marrow and other tissue samples. With over 20 years of experience in flow cytometry, we have a wide range of experience in developing and validating assays to suit many different requirements including immunophenotyping, detection of intracellular / extracellular markers, antigen binding assays. With the capacity to simultaneously measure multiple parameters on hundreds of individual cells per second, flow cytometry is a powerful technology with a wide variety of applications in pharmaceutical development. BioCytex is working with worldwide pharmaceutical companies. …

79 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Biopredic International is committed to support Life Science Research by developing and distributing biological tools. We assist both academia and industries in drug development, drug discovery, cosmetic and chemical fields. Biopredic International delivers assays, tissues, cells and reagents including: > High quality hepatocytes (human and animal, fresh or cryopreserved) and other liver-derived products (microsomes, S9 fractions and cytosols) > Skin products (fresh or frozen), including human skin discs and skin sheets (full thickness, dermatomed, stratum corneum), skin cells (keratinocytes, fibroblasts), subcellular fractions... > Blood products, including whole blood, sera, plasma, PBMCs, lymphocytes, monocytes, dendritic cells, CD34... > And other products …

97 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

All you need is LAB! Generamos indicadores biológicos predictivos y cuantitativos en tus peces para optimizar la gestión sanitaria y el rendimiento productivo 🐟 Somos el único laboratorio de histopatología y bioquímica sanguínea veterinaria acreditado por INN según NCh-ISO 17025Of.2005. Chile y Brasil Fish pathology, Fish immunology, Fish physiology, Fish hematology, Histopathology, Aquamedicine, Genomics, Proteomics, Biotechnology, Smoltification, Biofactory, Biobusiness, Biomarkers, Fish vaccinology, Blood gasometry, Fish welfare, PoC Kits, Fish pathology + Artificial Intelligence, Lab Bioservices, and Lab Bioproducts

100 similar entities Type: Startup Activities: deeptech Technologies: A.I.

Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule

634 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Non-invasive white blood cell monitoring Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device. Medical Devices, Diagnostics, Medical Technology, Clinical Imaging, and Bioengineering

79 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. …

437 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

making a difference Greiner Bio-One: Innovative solutions for your hospitals, laboratories and research facilities We specialize in the development, production and distribution of high-quality plastic products for laboratories worldwide. As a reliable technology partner, we support hospitals, research institutions, laboratories as well as the diagnostic, pharmaceutical and biotechnology industries with customized solutions. Our focus: ☑ Preanalytics: We are setting new standards in safety and efficiency with innovative collection systems for blood, urine and saliva sampling. Our customized digital solutions (Greiner eHealth Technologies) optimize processes and increase patient safety in laboratories and medical practices. ☑ BioScience: We offer highly specialized products …

481 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Products and solutions for Raw Materials, Diagnostics and Pharma. MORE THAN DIAGNOSTICS! Highly specialized and customer-oriented, Certest Biotec consists of four divisions, including Raw Materials, Immunodiagnostics (Rapid Tests, Turbidimetry, and CLIA), Molecular Biology under the VIASURE brand, and Pharma. Certest Raw Materials provides high quality solutions for developing and manufacturing your IVD assays. Our expertise in protein expresión & purification, monoclonal antibodies develoment & manufacturing and primers & probes manufacturing offer to our customers a priceless support in their challenging proyects. Certest Immunodiagnostic -Rapid Test, Turbidimetry, CLIA- is committed to providing a comprehensive portfolio of diagnostic reagents for detecting infectious …

94 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

The Blood Service of the Finnish Red Cross produces safe and effective blood products and laboratory services for hospitals needed in the treatment of patients. We take care of collecting blood from voluntary blood donors in accordance with the needs of patient care. We also offer hospitals services that support stem cell and organ transplants. The blood service is a non-profit organization. Our annual budget is approximately 60 million. EUR and we employ about 500 people. We are part of a unique helping chain with donors and healthcare staff. blood products, laboratory services, stem cell and tissue services, cell therapies …

69 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Proteome Sciences is an established CRO to quantitate proteins and peptides in complex solid & fluid biological samples Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. SysQuant® and TMT®MS2 are unbiased methods for identifying and contextualising new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibratorTM provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. Targeted assay development using mass spectrometry delivers high sensitivity, interference-free biomarker …

88 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology